By John Lovett
LITTLE ROCK, Ark. — Will implementation of medical cannabis in Arkansas reduce the use of potentially deadly opioid painkillers?
Several medical studies indicate it will, but the conclusion of a recent study published by the National Center for Biotechnology Information concludes it will take a one-two punch of medical cannabis and prescription drug monitoring programs to decrease opioid-related mortality.
That same study, titled “Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality,” also showed opioid-related mortality rate was slower in states with medical cannabis laws than those simply with prescription drug monitoring programs.
The Arkansas Prescription Drug Monitoring Program was amended this year to “mandate prescribers check the prescription drug monitoring program when prescribing certain medications.”
Dr. Joe Goldstrich, an Iowa-based physician who works with those in Arkansas creating medical cannabis guidelines, has become a vocal proponent of cannabis as an alternative